Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1B | Q00975 | 15/20 | 0.55 |
| ▸ | HCRTR1 | O43613 | 4/20 | 0.42 |
| ▸ | HCRTR2 | O43614 | 4/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3249607 | 0.88 | CACNA1B (0.54) | CACNA1BHCRTR1HCRTR2HSD11B1 | |
| SCHEMBL2843378 | 0.88 | CACNA1B (0.54) | CACNA1BHCRTR1HCRTR2HSD11B1 | |
| SCHEMBL66427 | 0.85 | CACNA1B (0.64) | CACNA1BHCRTR1HCRTR2HSD11B1 | |
| SCHEMBL1335745 | 0.84 | CACNA1B (0.64) | CACNA1BHCRTR1HCRTR2 | |
| SCHEMBL2417232 | 0.83 | CACNA1B (0.50) | CACNA1BHCRTR1HCRTR2HSD11B1 | |
| SCHEMBL67592 | 0.83 | CACNA1B (0.50) | CACNA1BHCRTR1HCRTR2HSD11B1 | |
| SCHEMBL2840371 | 0.82 | CACNA1B (0.53) | CACNA1BHCRTR1HCRTR2HSD11B1 | |
| SCHEMBL3237975 | 0.82 | CACNA1B (0.53) | CACNA1BHCRTR1HCRTR2HSD11B1 | |
| SCHEMBL1337226 | 0.81 | CACNA1B (0.76) | CACNA1BHCRTR1HCRTR2 | |
| SCHEMBL1337195 | 0.81 | CACNA1B (0.76) | CACNA1BHCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010062927-A2 | NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA(C)PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS | ABBOTT LABORATORIES (US) | 2010-06-03 | — | — | WO | claimed |
| WO-2010062927-A2 | NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA(C)PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS | ABBOTT LABORATORIES (US) | 2010-06-03 | — | — | WO | disclosed |